% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England

1
Ratio of Prescribing of Antidepressant,
Hypnotic and Antipsychotic Drugs in General
Practice in England
2
Ratio of Spending on Antidepressant,
Hypnoticand Antipsychotic Drugs in General
Practice in England
3
Trends in Prescribing of Hypnotics in General
Practice in England
4
Trends in Spending on Hypnotics in General
Practice in England
5
Quantities of "Z" drugs (Zaleplon, Zolpidem
Zopiclone) Prescribedin General Practice in
England (Quarter to June 2008)
6
Quantities of Selected Hypnotics
(Tabs/Caps)Prescribed in General Practice in
England(Quarter to June 2008)
7
of Prescriptions for Selected Hypnotics
(Tabs/Caps) in General Practice in England for
Defined Quantities(Quarter to June 2008)
8
Trends in Prescribing of Anxiolytics in General
Practice in England
9
Trends in Spending on Anxiolytics in General
Practice in England
10
Trends in Prescribing of Antipsychotic Drugs (BNF
4.2.1) in General Practice in England
11
Trends in Spending on Antipsychotic Drugs (BNF
4.2.1) in General Practice in England
12
Trends in Prescribing of "Typical" Antipsychotics
in General Practice in England
13
Trends in Spending on "Typical" Antipsychotics in
General Practice in England
14
Trends in Prescribing of "Atypical"
Antipsychotics in General Practice in England
15
Trends in Spending on "Atypical" Antipsychotics
in General Practice in England
16
Trends in Prescribing of Olanzapine Tablets by
Strength in General Practice in England
17
Trends in Prescribing of Quetiapine by Strength
in General Practice in England
18
Trends in Prescribing of Risperidone Tablets by
Strength in General Practice in England
19
Trends in Prescribing of and Spending on Valproic
Acid (Depakote) in General Practice in England
20
Trends in Prescribing of and Spending on Lithium
in General Practice in England
21
Trends in Prescribing of Antidepressants in
General Practice in England
22
Trends in Spending on Antidepressants in General
Practice in England
23
Trends in Prescribing of Tricyclic and related
antidepressants in General Practice in England
24
Trends in Spending on Tricyclic and related
antidepressantsin General Practice in England
25
Trends in Prescribing of SSRIs in General
Practice in England
26
Trends in Spending on SSRIs in General Practice
in England
27
Trends in Prescribing of Other Antidepressant
drugs (BNF 4.3.4) in General Practice in England
28
Trends in Spending on Other Antidepressant drugs
(BNF 4.3.4) in General Practice in England
29
Trends in Prescribing of and Spending on
Atomoxetinein General Practice in England
30
Trends in Prescribing of and Spending on
Methylphenidate in General Practice in England
31
Trends in Prescribing of Methylphenidate
Preparations in General Practice in England
32
Trends in Spending on Methylphenidate
Preparations in General Practice in England
33
Trends in Prescribing of Methadone in General
Practice in England
34
Trends in Spending on Methadone in General
Practice in England
35
Trends in Prescribing of Methadone (Excluding
Liquid Formulations) in General Practice in
England
36
Trends in Prescribing of Older Antiepileptic
Drugs in General Practice in England
37
Trends in Spending on Older Antiepileptic Drugs
in General Practice in England
38
Trends in Prescribing of Newer Antiepileptic
Drugs in General Practice in England
39
Trends in Spending on Newer Antiepileptic Drugs
in General Practice in England
40
Trends in Prescribing of Co-beneldopa and
Co-careldopa in General Practice in England
41
Trends in Spending on Co-beneldopa and
Co-careldopa in General Practice in England
42
Trends in Prescribing of Other Dopaminergic Drugs
used in Parkinsonism in General Practice in
England
43
Trends in Spending on Other Dopaminergic Drugs
used in Parkinsonism in General Practice in
England
44
Trends in Prescribing of Antimuscarinic Drugs in
General Practice in England
45
Trends in Spending on Antimuscarinic Drugs in
General Practice in England
46
Trends in Prescribing of and Spending on
Buprenorphine and Buprenorphine / Naloxone(BNF
4.10 Opioid Dependence) in General Practice in
England
47
Trends in Prescribing of and Spending on
Lofexidinein General Practice in England
48
Trends in Prescribing of and Spending on
Naltrexonein General Practice in England
49
Trends in Prescribing of Drugs for Dementiain
General Practice in England
50
Trends in Spending on Drugs for Dementiain
General Practice in England
51
Trends in Prescribing of Melatonin in General
Practice in England
52
Trends in Spending on Melatonin in General
Practice in England
53
Trends in Instalment Dispensing Forms in General
Practice in England